COMPASS Pathways (CMPS) Short Interest Ratio & Short Volume $4.41 -0.04 (-0.90%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends COMPASS Pathways Short Interest DataCOMPASS Pathways (CMPS) has a short interest of 5.45 million shares. This marks a -6.20% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.3, indicating that it would take 7.3 days of the average trading volume of 633,018 shares to cover all short positions.Current Short Interest5,450,000 sharesPrevious Short Interest5,810,000 sharesChange Vs. Previous Month-6.20%Dollar Volume Sold Short$25.94 millionShort Interest Ratio7.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares68,420,000 sharesPercentage of Shares Shorted7.97%Today's Trading Volume724,161 sharesAverage Trading Volume633,018 sharesToday's Volume Vs. Average114% Short Selling COMPASS Pathways? Sign up to receive the latest short interest report for COMPASS Pathways and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCMPS Short Interest Over TimeCMPS Days to Cover Over TimeCMPS Percentage of Float Shorted Over Time Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. COMPASS Pathways Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20245,450,000 shares $25.94 million -6.2%N/A7.3 $4.76 10/15/20245,810,000 shares $34.51 million -9.1%N/A11.5 $5.94 9/30/20246,390,000 shares $40.26 million +8.9%N/A12.4 $6.30 9/15/20245,870,000 shares $42.56 million +4.8%N/A13.2 $7.25 8/31/20245,600,000 shares $41.89 million +19.7%N/A12.8 $7.48 8/15/20244,680,000 shares $32.99 million +21.6%N/A10.4 $7.05 Get the Latest News and Ratings for CMPS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for COMPASS Pathways and its competitors with MarketBeat's FREE daily newsletter. 7/31/20243,850,000 shares $29.38 million -11.9%N/A9.3 $7.63 7/15/20244,370,000 shares $31.11 million +2.1%N/A10.7 $7.12 6/30/20244,280,000 shares $25.85 million +0.9%N/A10.6 $6.04 6/15/20244,240,000 shares $28.24 million +17.5%N/A8.5 $6.66 5/31/20243,610,000 shares $26.64 million +5.6%N/A6.9 $7.38 5/15/20243,420,000 shares $28.32 million +0.3%N/A5.8 $8.28 4/30/20243,410,000 shares $29.22 million +2.1%N/A5.3 $8.57 4/15/20243,340,000 shares $27.79 million +6.7%N/A4.7 $8.32 3/31/20243,130,000 shares $26.04 million -0.6%N/A4.3 $8.32 3/15/20243,150,000 shares $31.19 million -15.8%N/A4.6 $9.90 2/29/20243,740,000 shares $38.41 million -4.6%N/A4.9 $10.27 2/15/20243,920,000 shares $41.63 million +10.4%N/A5.8 $10.62 1/31/20243,550,000 shares $40.01 million +1.7%N/A5.7 $11.27 1/15/20243,490,000 shares $29.46 million +14.1%N/A6.6 $8.44 12/31/20233,060,000 shares $26.78 million -29.7%N/A5.7 $8.75 12/15/20234,350,000 shares $34.80 million +12.7%N/A8.3 $8.00 11/30/20233,860,000 shares $23.08 million -1.3%N/A8.4 $5.98 11/15/20233,910,000 shares $23.46 million -4.4%N/A8.9 $6.00 10/31/20234,090,000 shares $23.44 million +0.5%N/A8.7 $5.73 10/15/20234,070,000 shares $24.38 million -1.0%N/A9.1 $5.99 9/30/20234,110,000 shares $30.41 million +4.3%N/A9.1 $7.40 9/15/20233,940,000 shares $37.08 million +0.3%N/A9.2 $9.41 8/31/20233,930,000 shares $35.57 million +3.2%N/A10.6 $9.05 8/15/20233,810,000 shares $29.11 million +3.5%N/A11.1 $7.64 7/31/20233,680,000 shares $34.30 million +6.4%N/A12.4 $9.32 7/15/20233,460,000 shares $31.43 million +44.2%N/A12.1 $9.09 6/30/20232,400,000 shares $19.87 million -1.2%N/A9.1 $8.28 6/15/20232,430,000 shares $19.56 million -3.2%N/A9.6 $8.05 5/31/20232,510,000 shares $18.42 million -8.1%N/A9.5 $7.34 5/15/20232,730,000 shares $23.31 million -0.4%N/A10.2 $8.54 4/30/20232,740,000 shares $21.97 million -1.1%N/A9.9 $8.02 4/15/20232,770,000 shares $27.53 million -35.1%N/A9.7 $9.94 3/31/20234,270,000 shares $42.40 million -6.4%N/A14 $9.93 3/15/20234,560,000 shares $37.48 million -0.7%N/A17 $8.22War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. 2/28/20234,590,000 shares $37.87 million +2.9%N/A17.4 $8.25 2/15/20234,460,000 shares $41.88 million +8.5%N/A17.1 $9.39 1/31/20234,110,000 shares $42.66 million +2.5%N/A15.3 $10.38 1/15/20234,010,000 shares $38.30 million +3.6%N/A14.3 $9.55 12/30/20223,870,000 shares $31.08 million -0.8%N/A13.4 $8.03 12/15/20223,900,000 shares $38.03 million No ChangeN/A13 $9.75 11/30/20223,900,000 shares $40.17 million -1.5%N/A12.5 $10.30 11/15/20223,960,000 shares $42.29 million +1.3%N/A11.9 $10.68 10/31/20223,910,000 shares $41.21 million +0.3%N/A10.9 $10.54 10/15/20223,900,000 shares $36.89 million +1.0%N/A10.5 $9.46 9/30/20223,860,000 shares $41.42 million +0.3%N/A10.2 $10.73 9/15/20223,850,000 shares $56.36 million +5.8%N/A10.6 $14.64 8/31/20223,640,000 shares $59.48 million +7.4%N/A10 $16.34 8/15/20223,390,000 shares $60.65 million -2.6%N/A9.6 $17.89 7/31/20223,480,000 shares $54.25 million -4.1%N/A9.6 $15.59 7/15/20223,630,000 shares $43.89 million +5.2%N/A10.6 $12.09 6/30/20223,450,000 shares $37.33 million +16.6%N/A11 $10.82 6/15/20222,960,000 shares $27.85 million -3.3%N/A9.7 $9.41 5/31/20223,060,000 shares $27.82 million +1.3%N/A10.2 $9.09 5/15/20223,020,000 shares $23.04 million +8.2%N/A10 $7.63 4/30/20222,790,000 shares $25.28 million +3.0%N/A10.3 $9.06 4/15/20222,710,000 shares $34.15 million +9.3%N/A10.2 $12.60 3/31/20222,480,000 shares $31.97 million +9.3%N/A7.8 $12.89 3/15/20222,270,000 shares $26.08 million No ChangeN/A6.3 $11.49 2/28/20222,270,000 shares $32.78 million +9.7%N/A5.1 $14.44 2/15/20222,070,000 shares $31.51 million +13.1%N/A4.2 $15.22 1/31/20221,830,000 shares $28.82 million +16.6%N/A2.5 $15.75 1/15/20221,570,000 shares $28.10 million +3.3%N/A2 $17.90 12/31/20211,520,000 shares $33.59 million +68.6%N/A1.9 $22.10 12/15/2021901,400 shares $21.39 million +11.5%N/A1.2 $23.73 11/30/2021808,700 shares $26.85 million -16.6%N/A1.2 $33.20 11/15/2021970,000 shares $33.86 million -13.4%N/A1.6 $34.91 10/29/20211,120,000 shares $47.26 million +44.7%N/A2 $42.20 10/15/2021774,200 shares $24.94 million +38.2%N/A2.2 $32.22 9/30/2021560,300 shares $16.74 million -0.2%N/A1.7 $29.87 9/15/2021561,300 shares $18.27 million +38.0%N/A1.6 $32.55 8/31/2021406,900 shares $13.79 million -35.3%N/A1.1 $33.90 8/13/2021629,200 shares $19.04 million +16.0%N/A1.6 $30.26 7/30/2021542,300 shares $19.24 million +16.1%1.5%1.3 $35.48 7/15/2021467,100 shares $16.24 million -64.1%1.3%1 $34.76 6/30/20211,300,000 shares $49.60 million -12.8%3.6%2.7 $38.15 6/15/20211,490,000 shares $56.49 million -8.6%4.1%3.3 $37.91 5/28/20211,630,000 shares $56.56 million -12.8%4.5%3.7 $34.70 5/14/20211,870,000 shares $61.32 million +4.5%5.2%4.2 $32.79 4/30/20211,790,000 shares $69.74 million -2.7%5.1%3.8 $38.96 4/15/20211,840,000 shares $66.15 million +14.3%5.2%4.7 $35.95 3/31/20211,610,000 shares $56.83 million +5.9%4.6%4.1 $35.30 3/15/20211,520,000 shares $62.78 million +28.8%4.3%4 $41.30 2/26/20211,180,000 shares $56.89 million +24.6%3.3%3.1 $48.21 2/12/2021947,300 shares $47.35 million -5.3%2.7%2.4 $49.98War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. 1/29/20211,000,000 shares $43.97 million +4.3%N/A3 $43.97 1/15/2021959,200 shares $41.08 million No ChangeN/A2.6 $42.83 CMPS Short Interest - Frequently Asked Questions What is COMPASS Pathways' current short interest? Short interest is the volume of COMPASS Pathways shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 5,450,000 shares of CMPS short. Learn More on COMPASS Pathways' current short interest. What is a good short interest ratio for COMPASS Pathways? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMPS shares currently have a short interest ratio of 7.0. Learn More on COMPASS Pathways's short interest ratio. Which institutional investors are shorting COMPASS Pathways? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of COMPASS Pathways: Wolverine Trading LLC, and Walleye Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is COMPASS Pathways' short interest increasing or decreasing? COMPASS Pathways saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 5,450,000 shares, a drop of 6.2% from the previous total of 5,810,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does COMPASS Pathways' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to COMPASS Pathways: Sage Therapeutics, Inc. (11.91%), MacroGenics, Inc. (9.41%), Repare Therapeutics Inc. (2.61%), Ardelyx, Inc. (10.16%), Arcutis Biotherapeutics, Inc. (23.72%), Calliditas Therapeutics AB (publ) (0.01%), Rocket Pharmaceuticals, Inc. (13.05%), ANI Pharmaceuticals, Inc. (10.27%), Mesoblast Limited (1.22%), Avadel Pharmaceuticals plc (9.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short COMPASS Pathways stock? Short selling CMPS is an investing strategy that aims to generate trading profit from COMPASS Pathways as its price is falling. CMPS shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against COMPASS Pathways? A short squeeze for COMPASS Pathways occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMPS, which in turn drives the price of the stock up even further. How often is COMPASS Pathways' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMPS, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Sage Therapeutics Short Interest Data MacroGenics Short Interest Data Repare Therapeutics Short Interest Data Ardelyx Short Interest Data Arcutis Biotherapeutics Short Interest Data Calliditas Therapeutics AB (publ) Short Interest Data Rocket Pharmaceuticals Short Interest Data ANI Pharmaceuticals Short Interest Data Mesoblast Short Interest Data Avadel Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMPS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding COMPASS Pathways plc Please log in to your account or sign up in order to add this asset to your watchlist. Share COMPASS Pathways With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
